Biogen DSO Ratio 2011-2026 | BIIB

Annual DSO Ratio Biogen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
50.7	57.9	62.5	58.4	57.6	51.5	62.7	67.4	69	55.5	52.3	59.3	56.7	63.2	58.8

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
69	50.7	58.9

Quarterly DSO Ratio Biogen

2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	61.9	-	57	56.4	57.3	-	56	53.2	28.9	61.2	51.7	47.4	49	46.7	47.7	47.5	50.2	50.7	52	53.2	54.6	49.3	53	53	52.4	45.8	44.5	45.5	44.6	39.4	40.3	43.2	45	44.7	47	48.7	45.4	38.3	41.2	43.6	48.7	44.2	45.2	44.1	44.9	40.2	40.7	44.1	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
61.9	28.9	47.8

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
ADMA Biologics ADMA	74.6	$ 15.57	-5.89 %	$ 3.71 B	USA
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
AbCellera Biologics ABCL	173	$ 3.58	-1.38 %	$ 1.07 B	Canada
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Anika Therapeutics ANIK	77.3	$ 14.19	-1.18 %	$ 208 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Aptorum Group Limited APM	20.6	$ 0.82	-0.73 %	$ 4.47 M	China
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Apellis Pharmaceuticals APLS	115	$ 20.24	1.91 %	$ 2.55 B	USA
ANI Pharmaceuticals ANIP	114	$ 75.6	-1.22 %	$ 1.46 B	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Athersys ATHX	22.6	-	3.77 %	$ 22.4 M	USA
AVEO Pharmaceuticals AVEO	47.5	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	105	$ 159.87	-2.57 %	$ 7.95 B	USA
BridgeBio Pharma BBIO	52.4	$ 65.73	-1.22 %	$ 12.6 B	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
Equillium EQ	33.2	$ 1.79	2.29 %	$ 62.2 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
BioMarin Pharmaceutical BMRN	88.9	$ 60.54	0.18 %	$ 11.6 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	4.13	$ 2.93	-8.44 %	$ 1.05 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Capricor Therapeutics CAPR	31.9	$ 25.74	0.94 %	$ 689 M	USA